2019 Diabetic Nephropathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

Date: April 24, 2019
Pages: 217
Price:
US$ 1,799.00
License [?]:
Publisher: VPAResearch
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: 2F04BE58D93EN
Leaflet:

Download PDF Leaflet

2019 Diabetic Nephropathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Diabetic Nephropathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Diabetic Nephropathy. It presents in-depth analysis of Diabetic Nephropathy clinical trials across markets and companies. The research work is for providing complete understanding into trends in Diabetic Nephropathy.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Diabetic Nephropathy clinical trials by-
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Diabetic Nephropathy

The research work is prepared through extensive and continuous research on Diabetic Nephropathy trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Diabetic Nephropathy patients are identified
  • The report includes panorama of Diabetic Nephropathy clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Diabetic Nephropathy clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Diabetic Nephropathy Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Diabetic Nephropathy Clinical Trials by Region
  2.2.2 Average Enrollment of Diabetic Nephropathy Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Diabetic Nephropathy Treatment, 2019

3. REGION WISE DIABETIC NEPHROPATHY CLINICAL TRIALS

3.1 Asia Pacific Diabetic Nephropathy Clinical Trials by Country
3.2 Europe Diabetic Nephropathy Clinical Trials by Country
3.3 North America Diabetic Nephropathy Clinical Trials by Country
3.4 Middle East and Africa Diabetic Nephropathy Clinical Trials by Country
3.5 South and Central America Diabetic Nephropathy Clinical Trials by Country

4. DIABETIC NEPHROPATHY CLINICAL TRIAL TRENDS

4.1 Start Year wise Diabetic Nephropathy Clinical Trials
4.2 Phase wise Diabetic Nephropathy Clinical Trials
4.3 Trial Status wise Diabetic Nephropathy Clinical Trials
4.4 Trial Type wise Diabetic Nephropathy Clinical Trials

5. DIABETIC NEPHROPATHY AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Diabetic Nephropathy Trials by Year
5.2 Average Enrollment in Diabetic Nephropathy Trials by Phase
5.3 Average Enrollment in Diabetic Nephropathy Trials by Status
5.4 Average Enrollment in Diabetic Nephropathy Trials by Type of Trial

6. COMPANIES PARTICIPATING IN DIABETIC NEPHROPATHY CLINICAL TRIALS

6.1 Diabetic Nephropathy Trials by Sponsor Type
6.2 Diabetic Nephropathy Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Diabetic Nephropathy Trials- Phase
7.2 Diabetic Nephropathy Trials- Phase
7.3 Diabetic Nephropathy Trials- Phase
7.4 Diabetic Nephropathy Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

LIST OF FIGURES

Figure 1: Diabetic Nephropathy Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Figure 5: Europe – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Figure 7: North America – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Figure 9: Diabetic Nephropathy Clinical Trials by Phase
Figure 10: Diabetic Nephropathy Clinical Trials by Trial Status
Figure 11: Diabetic Nephropathy Clinical Trials by Type
Figure 12: Diabetic Nephropathy Clinical Trials by Sponsor Type
Figure 13: Diabetic Nephropathy Clinical Trials by Leading Sponsors
Figure 14: Diabetic Nephropathy Average Enrollment by Phase
Figure 15: Diabetic Nephropathy Average Enrollment by Trial Status
Figure 16: Diabetic Nephropathy Average Enrollment by Type
Figure 17: Diabetic Nephropathy- Average Enrolment by Type of Sponsors
Figure 18: Diabetic Nephropathy- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

LIST OF TABLES

Table 1: Diabetic Nephropathy Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Table 5: Europe – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Table 7: North America – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Diabetic Nephropathy Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Diabetic Nephropathy Average Enrollment by Phase
Table 15: Diabetic Nephropathy Average Enrollment by Trial Status
Table 16: Diabetic Nephropathy Average Enrollment by Type
Table 17: Diabetic Nephropathy- Average Enrolment by Type of Sponsors
Table 18: Diabetic Nephropathy- Enrolment by Leading Sponsors
Skip to top


Ask Your Question

2019 Diabetic Nephropathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: